Mark A Goldsmith
See Remarks at Revolution Medicines, Inc. (RVMD)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $57.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 18SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 213267,117 held (−0%) | $195.01 | $42K | -2.7% |
| Sep 18SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 13,775253,342 held (−5%) | $199.30 | $2.7M | -4.8% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 5,128342,202 held (−1%) | $207.23 | $1.1M | -8.4% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 24,917317,285 held (−7%) | $208.37 | $5.2M | -8.9% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 35,938281,347 held (−11%) | $209.26 | $7.5M | -9.3% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 3,813277,534 held (−1%) | $210.25 | $802K | -9.7% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 6,583270,951 held (−2%) | $211.33 | $1.4M | -10.2% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 3,621267,330 held (−1%) | $212.08 | $768K | -10.5% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 19064,234 held (−0%) | $207.25 | $39K | -8.4% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 95163,283 held (−1%) | $208.36 | $198K | -8.9% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 1,35161,932 held (−2%) | $209.28 | $283K | -9.3% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 13661,796 held (−0%) | $210.40 | $29K | -9.8% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 24561,551 held (−0%) | $211.47 | $52K | -10.3% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 12761,424 held (−0%) | $212.06 | $27K | -10.5% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 17764,247 held (−0%) | $207.25 | $37K | -8.4% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 93763,310 held (−1%) | $208.36 | $195K | -8.9% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 1,40561,905 held (−2%) | $209.27 | $294K | -9.3% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 12661,779 held (−0%) | $210.40 | $27K | -9.8% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 22961,550 held (−0%) | $211.46 | $48K | -10.3% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 12661,424 held (−0%) | $212.06 | $27K | -10.5% |
| Jun 18SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 10,020267,330 held (−4%) | $156.12 | $1.6M | +21.5% |
| Apr 17SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 120,000276,698 held (−30%) | $150.09 | $18.0M | +26.4% |
| Mar 19SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 12,871276,698 held (−4%) | $99.48 | $1.3M | +90.8% |
| Mar 3SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 700318,869 held (−0%) | $98.17 | $69K | +93.3% |
| Mar 3SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 3,500315,369 held (−1%) | $99.76 | $349K | +90.2% |
| Mar 3SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 3,620311,749 held (−1%) | $100.73 | $365K | +88.4% |
| Mar 3SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 21,329290,420 held (−7%) | $101.60 | $2.2M | +86.8% |
| Mar 3SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 851289,569 held (−0%) | $102.20 | $87K | +85.7% |
| Mar 3SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 10067,324 held (−0%) | $98.31 | $10K | +93.0% |
| Mar 3SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 40066,924 held (−1%) | $100.12 | $40K | +89.5% |
| Mar 3SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 1,70065,224 held (−3%) | $101.47 | $172K | +87.0% |
| Mar 3SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 80064,424 held (−1%) | $102.00 | $82K | +86.0% |
| Mar 3SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 10067,324 held (−0%) | $98.29 | $10K | +93.1% |
| Mar 3SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 60066,724 held (−1%) | $100.19 | $60K | +89.4% |
| Mar 3SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 2,10064,624 held (−3%) | $101.63 | $213K | +86.7% |
| Mar 3SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 20064,424 held (−0%) | $102.08 | $20K | +85.9% |
| Dec 18SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 15,394232,469 held (−6%) | $76.82 | $1.2M | +147.0% |
| Nov 26SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 60,000247,863 held (−19%) | $75.08 | $4.5M | +152.7% |
| Nov 26SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 3,00067,424 held (−4%) | $75.00 | $225K | +153.0% |
| Nov 26SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 3,00067,424 held (−4%) | $75.00 | $225K | +153.0% |
| Nov 20SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 20,000247,863 held (−7%) | $70.38 | $1.4M | +169.6% |
| Nov 14SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 20,000247,863 held (−7%) | $65.07 | $1.3M | +191.6% |
| Nov 12SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 30,000347,863 held (−8%) | $60.31 | $1.8M | +214.6% |
| Oct 20SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 10,000452,309 held (−2%) | $50.47 | $505K | +276.0% |
| Oct 20SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 10,000452,309 held (−2%) | $55.00 | $550K | +245.0% |
- Sell
See Remarks Mark A Goldsmith sold $42K of RVMD at $195.01 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Mark A Goldsmith sold $2.7M of RVMD at $199.30 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Mark A Goldsmith sold $1.1M of RVMD at $207.23 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Mark A Goldsmith sold $5.2M of RVMD at $208.37 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Mark A Goldsmith sold $7.5M of RVMD at $209.26 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Mark A Goldsmith sold $802K of RVMD at $210.25 — pre-scheduled 10b5-1 plan sale.